The efficacy and safety of Argon Plasma Coagulation therapy in Barrett's esophagus

Andrew J. Grade, Ifat A. Shah, Susan M. Medlin, Francisco C Ramirez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Thermo-ablation of Barrett's esophagus along with maximum acid suppression can induce re-epithelialization with squamous epithelium. Argon Plasma Coagulation (APC) is a new modality with a reported superficial depth of injury. Aim: To assess the technical feasibility, safety and early results of APC in Barrett's esophagus. Methods: Patients with circumferential Barrett's esophagus of at least 3 cm in length and without dysplasia were prospectively enrolled. APC was applied in one session to only one-half of the circumference (the other half served as control) until a white coagulum was observed. Time required to provide APC therapy, immediate and delayed events and complications were monitored. Each patient was kept on 60 mg/day of lansoprazole. EGD with biopsies every 1 cm from treated and untreated areas were repeated 4 weeks later using a jumbo biopsy forceps. Biopsies were examined by a pathologist blinded to the treated areas. Presence of endoscopically-appearing squamous epithelium in the treated areas and mucosal damage were evaluated at each follow-up. Setting: GI Section VA Medical Center. Results: Ten patients (51.9±1.9 years) with circumferential Barrett's esophagus (mean length: 3.2 cm) were enrolled. APC was applied using a 3.2 mm probe and settings of A60 watts with flow rates of 1.6mL/min. The mean time required to treat half of the circumference was 9.8 min. Two (20%) patients experienced mild-moderate but self-limited chest pain during the endoscopic session. Four (40%) patients had chest discomfort for 3-5 days after the procedure. There were no perforations. Eight patients have returned for endoscopic follow-up and endoscopically-appearing squamous epithelium in the APC treated areas was evident in all of them. Superficial ulcerations in the APC-treated areas were seen in 3 patients. No strictures were seen. The non-treated areas were read as Barrett's esophagus in all 8 patients at follow-up. Biopsies from the APC-treated areas uniformly revealed normal squamous epithelium in all patients. Three of 8 (37.5%) patients had evidence of intestinal metaplasia underneath the squamous epithelium. Conclusions: 1) APC resulted in re-epithelialization with normal superficial squamous epithelium. 2) Although APC was effective in squamous re-epithelialization, one-third of patients still showed abnormal metaplastic tissue underneath on histology. 3) At the settings used, APC was safe but it caused minor chest discomfort in 40% patients.

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume47
Issue number4
StatePublished - 1998
Externally publishedYes

Fingerprint

Argon Plasma Coagulation
Barrett Esophagus
Safety
Epithelium
Re-Epithelialization
Therapeutics
Biopsy
Thorax
Lansoprazole
Metaplasia
Chest Pain
Surgical Instruments

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The efficacy and safety of Argon Plasma Coagulation therapy in Barrett's esophagus. / Grade, Andrew J.; Shah, Ifat A.; Medlin, Susan M.; Ramirez, Francisco C.

In: Gastrointestinal Endoscopy, Vol. 47, No. 4, 1998.

Research output: Contribution to journalArticle

@article{b88a61c790a34456ac7269b24ab16d32,
title = "The efficacy and safety of Argon Plasma Coagulation therapy in Barrett's esophagus",
abstract = "Thermo-ablation of Barrett's esophagus along with maximum acid suppression can induce re-epithelialization with squamous epithelium. Argon Plasma Coagulation (APC) is a new modality with a reported superficial depth of injury. Aim: To assess the technical feasibility, safety and early results of APC in Barrett's esophagus. Methods: Patients with circumferential Barrett's esophagus of at least 3 cm in length and without dysplasia were prospectively enrolled. APC was applied in one session to only one-half of the circumference (the other half served as control) until a white coagulum was observed. Time required to provide APC therapy, immediate and delayed events and complications were monitored. Each patient was kept on 60 mg/day of lansoprazole. EGD with biopsies every 1 cm from treated and untreated areas were repeated 4 weeks later using a jumbo biopsy forceps. Biopsies were examined by a pathologist blinded to the treated areas. Presence of endoscopically-appearing squamous epithelium in the treated areas and mucosal damage were evaluated at each follow-up. Setting: GI Section VA Medical Center. Results: Ten patients (51.9±1.9 years) with circumferential Barrett's esophagus (mean length: 3.2 cm) were enrolled. APC was applied using a 3.2 mm probe and settings of A60 watts with flow rates of 1.6mL/min. The mean time required to treat half of the circumference was 9.8 min. Two (20{\%}) patients experienced mild-moderate but self-limited chest pain during the endoscopic session. Four (40{\%}) patients had chest discomfort for 3-5 days after the procedure. There were no perforations. Eight patients have returned for endoscopic follow-up and endoscopically-appearing squamous epithelium in the APC treated areas was evident in all of them. Superficial ulcerations in the APC-treated areas were seen in 3 patients. No strictures were seen. The non-treated areas were read as Barrett's esophagus in all 8 patients at follow-up. Biopsies from the APC-treated areas uniformly revealed normal squamous epithelium in all patients. Three of 8 (37.5{\%}) patients had evidence of intestinal metaplasia underneath the squamous epithelium. Conclusions: 1) APC resulted in re-epithelialization with normal superficial squamous epithelium. 2) Although APC was effective in squamous re-epithelialization, one-third of patients still showed abnormal metaplastic tissue underneath on histology. 3) At the settings used, APC was safe but it caused minor chest discomfort in 40{\%} patients.",
author = "Grade, {Andrew J.} and Shah, {Ifat A.} and Medlin, {Susan M.} and Ramirez, {Francisco C}",
year = "1998",
language = "English (US)",
volume = "47",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - The efficacy and safety of Argon Plasma Coagulation therapy in Barrett's esophagus

AU - Grade, Andrew J.

AU - Shah, Ifat A.

AU - Medlin, Susan M.

AU - Ramirez, Francisco C

PY - 1998

Y1 - 1998

N2 - Thermo-ablation of Barrett's esophagus along with maximum acid suppression can induce re-epithelialization with squamous epithelium. Argon Plasma Coagulation (APC) is a new modality with a reported superficial depth of injury. Aim: To assess the technical feasibility, safety and early results of APC in Barrett's esophagus. Methods: Patients with circumferential Barrett's esophagus of at least 3 cm in length and without dysplasia were prospectively enrolled. APC was applied in one session to only one-half of the circumference (the other half served as control) until a white coagulum was observed. Time required to provide APC therapy, immediate and delayed events and complications were monitored. Each patient was kept on 60 mg/day of lansoprazole. EGD with biopsies every 1 cm from treated and untreated areas were repeated 4 weeks later using a jumbo biopsy forceps. Biopsies were examined by a pathologist blinded to the treated areas. Presence of endoscopically-appearing squamous epithelium in the treated areas and mucosal damage were evaluated at each follow-up. Setting: GI Section VA Medical Center. Results: Ten patients (51.9±1.9 years) with circumferential Barrett's esophagus (mean length: 3.2 cm) were enrolled. APC was applied using a 3.2 mm probe and settings of A60 watts with flow rates of 1.6mL/min. The mean time required to treat half of the circumference was 9.8 min. Two (20%) patients experienced mild-moderate but self-limited chest pain during the endoscopic session. Four (40%) patients had chest discomfort for 3-5 days after the procedure. There were no perforations. Eight patients have returned for endoscopic follow-up and endoscopically-appearing squamous epithelium in the APC treated areas was evident in all of them. Superficial ulcerations in the APC-treated areas were seen in 3 patients. No strictures were seen. The non-treated areas were read as Barrett's esophagus in all 8 patients at follow-up. Biopsies from the APC-treated areas uniformly revealed normal squamous epithelium in all patients. Three of 8 (37.5%) patients had evidence of intestinal metaplasia underneath the squamous epithelium. Conclusions: 1) APC resulted in re-epithelialization with normal superficial squamous epithelium. 2) Although APC was effective in squamous re-epithelialization, one-third of patients still showed abnormal metaplastic tissue underneath on histology. 3) At the settings used, APC was safe but it caused minor chest discomfort in 40% patients.

AB - Thermo-ablation of Barrett's esophagus along with maximum acid suppression can induce re-epithelialization with squamous epithelium. Argon Plasma Coagulation (APC) is a new modality with a reported superficial depth of injury. Aim: To assess the technical feasibility, safety and early results of APC in Barrett's esophagus. Methods: Patients with circumferential Barrett's esophagus of at least 3 cm in length and without dysplasia were prospectively enrolled. APC was applied in one session to only one-half of the circumference (the other half served as control) until a white coagulum was observed. Time required to provide APC therapy, immediate and delayed events and complications were monitored. Each patient was kept on 60 mg/day of lansoprazole. EGD with biopsies every 1 cm from treated and untreated areas were repeated 4 weeks later using a jumbo biopsy forceps. Biopsies were examined by a pathologist blinded to the treated areas. Presence of endoscopically-appearing squamous epithelium in the treated areas and mucosal damage were evaluated at each follow-up. Setting: GI Section VA Medical Center. Results: Ten patients (51.9±1.9 years) with circumferential Barrett's esophagus (mean length: 3.2 cm) were enrolled. APC was applied using a 3.2 mm probe and settings of A60 watts with flow rates of 1.6mL/min. The mean time required to treat half of the circumference was 9.8 min. Two (20%) patients experienced mild-moderate but self-limited chest pain during the endoscopic session. Four (40%) patients had chest discomfort for 3-5 days after the procedure. There were no perforations. Eight patients have returned for endoscopic follow-up and endoscopically-appearing squamous epithelium in the APC treated areas was evident in all of them. Superficial ulcerations in the APC-treated areas were seen in 3 patients. No strictures were seen. The non-treated areas were read as Barrett's esophagus in all 8 patients at follow-up. Biopsies from the APC-treated areas uniformly revealed normal squamous epithelium in all patients. Three of 8 (37.5%) patients had evidence of intestinal metaplasia underneath the squamous epithelium. Conclusions: 1) APC resulted in re-epithelialization with normal superficial squamous epithelium. 2) Although APC was effective in squamous re-epithelialization, one-third of patients still showed abnormal metaplastic tissue underneath on histology. 3) At the settings used, APC was safe but it caused minor chest discomfort in 40% patients.

UR - http://www.scopus.com/inward/record.url?scp=0009576931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0009576931&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0009576931

VL - 47

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -